NCT05353504

Brief Summary

The investigators aim to test the hypothesis that a microbiome-changing dietary intervention improves food decision-making and to determine the underlying microbiotal and metabolic mechanisms. To this end, 90 overweight/obese adults will be enrolled in a randomized controlled trial to test the effects of a pre-biotic dietary intervention (supplementary intake of soluble fibre) or a behavioural lifestyle intervention (weekly educational program) vs. control condititon (supplementary intake of isocaloric starch) over a period of 26 weeks. Before and after the intervention/control period, participants will undergo task-based functional and structural MRI and cognitive testing. The gut microbiota will be assessed using 16S rDNA next-generation sequencing (V3/V4 region) in stool samples. Diet, anthropometry and lifestyle will be monitored with questionnaires and metabolomics will be assayed in peripheral blood and stool (e.g. SCFA). Using a modulation of gut-brain communication through a prebiotic diet and lifestyle intervention, respectively, the investigators will be able to discover microbiota communities that play a key role for eating behaviour. Related mechanistic insights could help to develop novel preventive and therapeutic options to combat unhealthy weight gain in our obesogenic society.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Mar 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Mar 2022Dec 2026

Study Start

First participant enrolled

March 8, 2022

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

March 23, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 29, 2022

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

April 29, 2022

Status Verified

April 1, 2022

Enrollment Period

2.7 years

First QC Date

March 23, 2022

Last Update Submit

April 26, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • blood-oxygenation-level-dependent (BOLD) activity during food wanting

    BOLD-acitvity will be measured using event-related echo-planar T2\*-weighted magnetic resonance imaging (MRI) during food wanting task according to previously described procedures (details of preprocessing at: https://osf.io/ynkxw). Onsets of food and art stimuli presentation will be modelled as separate regressors convolving delta functions with a canonical hemodynamic response function. Wanting rating scores (on an 8-point likert scale) per stimulus will be added as covariates. In a parallel model, kcal of food stimuli will be added multiplied with wanting scores to model high caloric food wanting interaction. At the group level, we will assess the contrasts food \> art and wanting modulation.

    6 months

Secondary Outcomes (16)

  • microbial alpha and beta diversity

    6 months

  • fMRI BOLD activity memory performance

    6 months

  • satiety

    6 months

  • ghrelin

    6 months

  • leptin

    6 months

  • +11 more secondary outcomes

Study Arms (3)

prebiotic dietary supplement

ACTIVE COMPARATOR

high-dose daily inulin

Dietary Supplement: Inulin

behavioural lifestyle intervention

EXPERIMENTAL

new educational program to change eating behaviour, provided through weekly sessions.

Behavioral: Lifestyle intervention

placebo dietary supplement

PLACEBO COMPARATOR

equicaloric daily maltodextrin

Dietary Supplement: Placebo

Interventions

InulinDIETARY_SUPPLEMENT

28g/day delivered in 2 sachets throughout the day with main meals

prebiotic dietary supplement

weekly educational sessions to improve individual's eating behaviour

behavioural lifestyle intervention
PlaceboDIETARY_SUPPLEMENT

equicaloric maltodextrin delivered in 2 sachets throughout the day with main meals

placebo dietary supplement

Eligibility Criteria

Age18 Years - 60 Years
Sexall(Gender-based eligibility)
Gender Eligibility Detailsall genders, self-report
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • BMI \>= 25 kg/m2 or WHR \>= 0.9/0.85 (m/d, f)
  • no MRI contra-indication
  • written informed consent

You may not qualify if:

  • athletes
  • occurrence of a clinically relevant psychiatric disease in the last 12 months, e.g. depression, substance abuse, eating disorders, schizophrenia
  • any chronic inflammatory or malignant disease
  • type 1 diabetes
  • previous bariatric/gastric surgery
  • pregnancy or breastfeeding woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences

Leipzig, Germany

RECRUITING

Related Publications (1)

  • Vartanian M, Endres KJ, Lee YT, Friedrich S, Meemken MT, Schamarek I, Rohde-Zimmermann K, Schurfeld R, Eisenberg L, Hilbert A, Beyer F, Stumvoll M, Sacher J, Villringer A, Christensen JF, Witte AV. Investigating the impact of microbiome-changing interventions on food decision-making: MIFOOD study protocol. BMC Nutr. 2025 Jan 13;11(1):8. doi: 10.1186/s40795-024-00971-6.

MeSH Terms

Conditions

OverweightObesity

Interventions

Inulin

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

StarchGlucansBiopolymersPolymersMacromolecular SubstancesDietary CarbohydratesCarbohydratesFructansPolysaccharides

Study Officials

  • Veronica Witte, PhD

    Cognitive Neurology, University Medical Center Leipzig

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Meghedi Vartanian, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
People will be randomly assigned to the three arms and blinded towards receipt of dietary fibre supplement or placebo supplement. However, behavioural lifestyle intervention arm cannot be blinded to participants.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 23, 2022

First Posted

April 29, 2022

Study Start

March 8, 2022

Primary Completion

December 1, 2024

Study Completion (Estimated)

December 1, 2026

Last Updated

April 29, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will share

We plan to share all data openly but anonymized on secured German servers of the institute after registration with ID.

Shared Documents
STUDY PROTOCOL, SAP, ANALYTIC CODE
Time Frame
after end of study for 5 years or longer
Access Criteria
Registration on a website, providing copy of ID

Locations